Navigation Links
Biophysical Society announces winners of 2014 Minority Affairs Committee Travel Awards
Date:1/22/2014

Rockville, MD The Biophysical Society has announced the winner of its Minority Affairs Committee Travel Awards to attend the Biophysical Society's 58th Annual Meeting at the Moscone Center in San Francisco, February 15-19, 2014. The awards are meant to encourage participation at the Biophysical Society Annual Meeting by minority students and postdoctoral fellows currently studying biophysics. Recipients will be honored at a reception on Saturday, February 15.

The 2014 recipients of the Minority Travel Award are:

  • Marcio Duarte Albasini Mourao, The Mathematical Biosciences Institute, UNRAVELLING THE IMPACT OF OBSTACLES IN DIFFUSION AND KINETICS OF AN ENZYME CATALYSED REACTION

  • Jeremiah Babcock, University of Texas, San Antonio, THE TRANSPORTATION POTENTIAL OF HUMAN SERUM ALBUMIN FOR MIR106A

  • Rene Barro-Soria, University of Miami, Miller School of Medicine, KCNE1 SEPARATES THE MAIN VOLTAGE SENSOR MOVEMENT AND CHANNEL OPENING IN KCNQ1/KCNE1 CHANNELS

  • Ashton Brock, University of Virginia, INFLUENCE OF DETERGENT PROPERTIES ON THE SOLUBILIZATION AND FUNCTION OF MEMBRANE PROTEINS

  • Jodian Brown, University of Maryland Baltimore County, UNDERSTANDING THE MOLECULAR MECHANISM OF SYNERGISTIC INHIBITION IN THE HEPATITIS C VIRUS (HCV) POLYMERASE USING MOLECULAR DYNAMICS SIMULATIONS AND FREE ENERGY CALCULATIONS

  • Igal Bucay, University of North Carolina, Chapel Hill, DETERMINANTS OF FIBRINOLYSIS IN SINGLE FIBRIN FIBERS.

  • James Campbell, Baylor College of Medicine, INSIGHTS INTO THE CYCLIC NUCLEOTIDE SELECTIVITY MECHANISM OF CYCLIC GMP DEPENDENT PROTEIN KINASE II

  • Jacqueline Esquiaqui, University of Florida, STUDYING DYNAMICS AND CONFORMATIONAL CHANGES IN THE GLYCINE RIBOSWITCH USING ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY

  • Liezl Francisco, University of Texas Health Science Center at San Antonio, SMALL MOLECULE INHIBITORS OF INTERACTION BETWEE
    '/>"/>

Contact: Laura Phelan
lphelan@biophysics.org
Biophysical Society
Source:Eurekalert

Page: 1 2

Related biology news :

1. Biophysical Society names 5 2013 award recipients
2. Biophysical Society names 2013 Distinguished Service, Emily M. Gray, and Founders awardees
3. Biophysical Society announces winners of 2013 CPOW travel awards
4. Biophysical Society announces winners of 2013 Education Committee travel awards
5. Biophysical Society announces winners of 2013 international travel awards
6. Biophysical Society announces 2013 New and Notable Symposium speakers
7. Media invited: Biophysical Society Annual Meeting
8. Biophysical Society announces speakers for Future of Biophysics Burroughs Wellcome Fund Symposium
9. Biophysical Society Annual Meeting
10. Biophysical Society announces winners of 2014 CPOW Travel Awards
11. Geological Society of America Cordilleran section meets in the heart of Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 /PRNewswire/ ... ) has announced the addition of the ... report to their offering. ... This insight provides an overview of the ... Watermarking aims to control and monitor piracy ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., ... of a study that pinpoints fine-scale differences in genetic ... States . Since immigrants first arrived ... United States has served as a meeting ... how American history and the ongoing mixing of peoples ...
(Date:12/17/2014)...  HITLAB SM announced today its completion ... confirm its adherence to current U.S. Food and ... to conduct regulated smart device and smart phone ... safety and research quality. "HITLAB is ... delivery with innovative technology," said Laura Pugliese ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... virus that introduces a blood pressure-lowering gene into cells and ... for four months promises to take gene therapy for the ... College of Medicine in a report released online in the ... pressure is one of the leading causes of death and ...
... in the region now known as Uganda's Kibale ... a primate still in decline. The logging practice, ... ecological balance for these monkeys, leading to behavioral ... infections. , The researchers focused on three primate ...
... grass that can grow 13 feet high, may be a ... University of Illinois at Urbana-Champaign say. , Stephen P. ... recently took that message to Dublin, Ireland, where the British ... Festival of Science Sept. 3-10. , Closer to home, two ...
Cached Biology News:Gene therapy to lower blood pressure just enough 2Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 2Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 3Hybrid grass may prove to be valuable fuel source 2Hybrid grass may prove to be valuable fuel source 3Hybrid grass may prove to be valuable fuel source 4
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a ... Drug Administration (FDA) for the use of Medtronic,s ... (including a newly developed catheter) for use with ... intravenously to patients with pulmonary arterial hypertension.   ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 GMO corn ... biotechnology company, Syngenta, are in the process of being ... The consolidated case is In Re: Syngenta AG MIR ... District Court for the District of Kansas. , Management ... been handed over to U.S. District Judge John W. ...
(Date:12/24/2014)... 23, 2014 The report ... as its definition, classification, application and industry ... manufacturing process, and product cost structure. Production ... The analysis also covers upstream raw materials, ... development trend and proposals. In the end, ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... Germany, May 3, 2012 , Point-of-Care ... Health program funded by Bill & Melinda Gates Foundation and ... and technologies will aid effort to create a low-cost portable ... , Development expected to be completed by ...
... for Clinical Research, Inc., a company focused on early ... record growth in the number of clinical trials in ... the number of mid-size biotech and off-shore clients, while ... driven by a strong demand for Phase I and ...
... Silence Therapeutics Plc (AIM: SLN), a leading international ... Quark Pharmaceuticals , has announced it has amended its existing ... to perform a Phase 2a clinical study to assess the ... function in patients with moderate and advanced Open-Angle Glaucoma (OAG). ...
Cached Biology Technology:QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 2QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 3QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 4QIAGEN Joins Grand Challenges in Global Health Initiative to Bring Advanced Point-of-Care Diagnostics to World's Poorest Countries 5Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline 2Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline 3Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 2Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 3Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 4Silence Therapeutics' Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silence's AtuRNAi in a New Indication 5
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
This adapter allows the Thermo-Fast® 96 Semi-Skirted (AB-0900 and AB-0990) PCR plates to be used directly in the ABI PRISM® 3100 sequencer without the need for software changes....
cystatin A (N-18)...
Human Cystatin A MAb (Clone 224705)...
Biology Products: